Literature DB >> 22775587

Optimization of a nanomedicine-based silicon phthalocyanine 4 photodynamic therapy (Pc 4-PDT) strategy for targeted treatment of EGFR-overexpressing cancers.

Alyssa M Master1, Megan Livingston, Nancy L Oleinick, Anirban Sen Gupta.   

Abstract

The current clinical mainstays for cancer treatment, namely, surgical resection, chemotherapy, and radiotherapy, can cause significant trauma, systemic toxicity, and functional/cosmetic debilitation of tissue, especially if repetitive treatment becomes necessary due to tumor recurrence. Hence there is significant clinical interest in alternate treatment strategies like photodynamic therapy (PDT) which can effectively and selectively eradicate tumors and can be safely repeated if needed. We have previously demonstrated that the second-generation photosensitizer Pc 4 (silicon phthalocyanine 4) can be formulated within polymeric micelles, and these micelles can be specifically targeted to EGFR-overexpressing cancer cells using GE11 peptide ligands, to enhance cell-specific Pc 4 delivery and internalization. In the current study, we report on the in vitro optimization of the EGFR-targeting, Pc 4 loading of the micellar nanoformulation, along with optimization of the corresponding photoirradiation conditions to maximize Pc 4 delivery, internalization, and subsequent PDT-induced cytotoxicity in EGFR-overexpressing cells in vitro. In our studies, absorption and fluorescence spectroscopy were used to monitor the cell-specific uptake of the GE11-decorated Pc 4-loaded micelles and the cytotoxic singlet oxygen production from the micelle-encapsulated Pc 4, to determine the optimum ligand density and Pc 4 loading. It was found that the micelle formulations bearing 10 mol % of GE11-modified polymer component resulted in the highest cellular uptake in EGFR-overexpressing A431 cells within the shortest incubation periods. Also, the loading of ∼ 50 μg of Pc 4 per mg of polymer in these micellar formulations resulted in the highest levels of singlet oxygen production. When formulations bearing these optimized parameters were tested in vitro on A431 cells for PDT effect, a formulation dose containing 400 nM Pc 4 and photoirradiation duration of 400 s at a fluence of 200 mJ/cm(2) yielded close to 100% cell death.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22775587      PMCID: PMC3498539          DOI: 10.1021/mp300256e

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  42 in total

Review 1.  Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency.

Authors:  A A Rosenkranz; D A Jans; A S Sobolev
Journal:  Immunol Cell Biol       Date:  2000-08       Impact factor: 5.126

Review 2.  Targeted photodynamic therapy via receptor mediated delivery systems.

Authors:  Wesley M Sharman; Johan E van Lier; Cynthia M Allen
Journal:  Adv Drug Deliv Rev       Date:  2004-01-13       Impact factor: 15.470

Review 3.  Cell death and growth arrest in response to photodynamic therapy with membrane-bound photosensitizers.

Authors:  Jacques Piette; Cédric Volanti; Annelies Vantieghem; Jean-Yves Matroule; Yvette Habraken; Patrizia Agostinis
Journal:  Biochem Pharmacol       Date:  2003-10-15       Impact factor: 5.858

Review 4.  Multicell tumor spheroids in photodynamic therapy.

Authors:  Steen J Madsen; Chung-Ho Sun; Bruce J Tromberg; Vittorio Cristini; Nzola De Magalhães; Henry Hirschberg
Journal:  Lasers Surg Med       Date:  2006-06       Impact factor: 4.025

Review 5.  Nanoparticles in photodynamic therapy: an emerging paradigm.

Authors:  Dev Kumar Chatterjee; Li Shan Fong; Yong Zhang
Journal:  Adv Drug Deliv Rev       Date:  2008-09-20       Impact factor: 15.470

6.  Monte carlo simulations of metallo-supramolecular micelles.

Authors:  Shihu Wang; Elena E Dormidontova
Journal:  Macromol Rapid Commun       Date:  2010-03-04       Impact factor: 5.734

Review 7.  Targeted photodynamic therapy--a promising strategy of tumor treatment.

Authors:  Andrzej M Bugaj
Journal:  Photochem Photobiol Sci       Date:  2011-05-06       Impact factor: 3.982

Review 8.  Engineered nanoparticles in cancer therapy.

Authors:  Natalie P Praetorius; Tarun K Mandal
Journal:  Recent Pat Drug Deliv Formul       Date:  2007

9.  Irradiation-induced enhancement of Pc 4 fluorescence and changes in light scattering are potential dosimeters for Pc 4-PDT.

Authors:  Ken Kang-Hsin Wang; Jeremy D Wilson; Malcolm E Kenney; Soumya Mitra; Thomas H Foster
Journal:  Photochem Photobiol       Date:  2007 Sep-Oct       Impact factor: 3.421

10.  EGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studies.

Authors:  Alyssa M Master; Yizhi Qi; Nancy L Oleinick; Anirban Sen Gupta
Journal:  Nanomedicine       Date:  2011-10-22       Impact factor: 5.307

View more
  12 in total

1.  Triple-responsive expansile nanogel for tumor and mitochondria targeted photosensitizer delivery.

Authors:  Huacheng He; Alexander W Cattran; Tu Nguyen; Anna-Liisa Nieminen; Peisheng Xu
Journal:  Biomaterials       Date:  2014-08-22       Impact factor: 12.479

2.  Activated T cells exhibit increased uptake of silicon phthalocyanine Pc 4 and increased susceptibility to Pc 4-photodynamic therapy-mediated cell death.

Authors:  David C Soler; Jennifer Ohtola; Hideaki Sugiyama; Myriam E Rodriguez; Ling Han; Nancy L Oleinick; Minh Lam; Elma D Baron; Kevin D Cooper; Thomas S McCormick
Journal:  Photochem Photobiol Sci       Date:  2016-05-10       Impact factor: 3.982

3.  Enhanced singlet oxygen production by photodynamic therapy and a novel method for its intracellular measurement.

Authors:  Sandra L Pena Luengas; Gustavo Horacio Marin; Kevin Aviles; Ricardo Cruz Acuña; Gustavo Roque; Felipe Rodríguez Nieto; Francisco Sanchez; Adrián Tarditi; Luis Rivera; Eduardo Mansilla
Journal:  Cancer Biother Radiopharm       Date:  2014-12       Impact factor: 3.099

4.  A cell-targeted photodynamic nanomedicine strategy for head and neck cancers.

Authors:  Alyssa Master; Anthony Malamas; Rachna Solanki; Dana M Clausen; Julie L Eiseman; Anirban Sen Gupta
Journal:  Mol Pharm       Date:  2013-04-24       Impact factor: 4.939

Review 5.  Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges.

Authors:  Alyssa Master; Megan Livingston; Anirban Sen Gupta
Journal:  J Control Release       Date:  2013-03-06       Impact factor: 9.776

Review 6.  Near-infrared light activated delivery platform for cancer therapy.

Authors:  Min Lin; Yan Gao; Francis Hornicek; Feng Xu; Tian Jian Lu; Mansoor Amiji; Zhenfeng Duan
Journal:  Adv Colloid Interface Sci       Date:  2015-10-14       Impact factor: 12.984

7.  Targeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancer.

Authors:  Dongsheng Wang; Baowei Fei; Luma V Halig; Xulei Qin; Zhongliang Hu; Hong Xu; Yongqiang Andrew Wang; Zhengjia Chen; Sungjin Kim; Dong M Shin; Zhuo Georgia Chen
Journal:  ACS Nano       Date:  2014-07-22       Impact factor: 15.881

Review 8.  Developments in PDT Sensitizers for Increased Selectivity and Singlet Oxygen Production.

Authors:  Nahid Mehraban; Harold S Freeman
Journal:  Materials (Basel)       Date:  2015-07-20       Impact factor: 3.623

Review 9.  EGFR-Targeted Photodynamic Therapy.

Authors:  Luca Ulfo; Paolo Emidio Costantini; Matteo Di Giosia; Alberto Danielli; Matteo Calvaresi
Journal:  Pharmaceutics       Date:  2022-01-20       Impact factor: 6.321

10.  Unveiling Ga(III) phthalocyanine-a different photosensitizer in neuroblastoma cellular model.

Authors:  Carolina Constantin; Andreea-Roxana Lupu; Tudor Emanuel Fertig; Mihaela Gherghiceanu; Sevinci Pop; Rodica-Mariana Ion; Monica Neagu
Journal:  J Cell Mol Med       Date:  2018-11-19       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.